These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 19544374)
1. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. Alvarez AI; Real R; Pérez M; Mendoza G; Prieto JG; Merino G J Pharm Sci; 2010 Feb; 99(2):598-617. PubMed ID: 19544374 [TBL] [Abstract][Full Text] [Related]
2. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity. Arias A; Rigalli JP; Villanueva SS; Ruiz ML; Luquita MG; Perdomo VG; Vore M; Catania VA; Mottino AD Toxicology; 2014 Jun; 320():46-55. PubMed ID: 24685904 [TBL] [Abstract][Full Text] [Related]
3. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly. Miller DS Adv Cancer Res; 2015; 125():43-70. PubMed ID: 25640266 [TBL] [Abstract][Full Text] [Related]
4. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship. Katayama K; Masuyama K; Yoshioka S; Hasegawa H; Mitsuhashi J; Sugimoto Y Cancer Chemother Pharmacol; 2007 Nov; 60(6):789-97. PubMed ID: 17345086 [TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Leslie EM; Deeley RG; Cole SP Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415 [TBL] [Abstract][Full Text] [Related]
6. The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs. Li Y; Paxton JW Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):267-85. PubMed ID: 23289831 [TBL] [Abstract][Full Text] [Related]
7. [The drug-drug interaction mediated by efflux transporters and CYP450 enzymes]. Wang C; Liu KX Yao Xue Xue Bao; 2014 May; 49(5):590-5. PubMed ID: 25151726 [TBL] [Abstract][Full Text] [Related]
8. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor. Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334 [TBL] [Abstract][Full Text] [Related]
9. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010 [TBL] [Abstract][Full Text] [Related]
10. Application and limitation of inhibitors in drug-transporter interactions studies. Wang Q; Strab R; Kardos P; Ferguson C; Li J; Owen A; Hidalgo IJ Int J Pharm; 2008 May; 356(1-2):12-8. PubMed ID: 18272304 [TBL] [Abstract][Full Text] [Related]
11. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP. Xiao L; Yi T; Chen M; Lam CW; Zhou H Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020 [TBL] [Abstract][Full Text] [Related]
12. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Gedeon C; Behravan J; Koren G; Piquette-Miller M Placenta; 2006; 27(11-12):1096-102. PubMed ID: 16460798 [TBL] [Abstract][Full Text] [Related]
13. Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum. Tucker TG; Milne AM; Fournel-Gigleux S; Fenner KS; Coughtrie MW Biochem Pharmacol; 2012 Jan; 83(2):279-85. PubMed ID: 22062654 [TBL] [Abstract][Full Text] [Related]
14. Interaction of Food Additives with Intestinal Efflux Transporters. Sjöstedt N; Deng F; Rauvala O; Tepponen T; Kidron H Mol Pharm; 2017 Nov; 14(11):3824-3833. PubMed ID: 28921988 [TBL] [Abstract][Full Text] [Related]
15. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Pedersen JM; Matsson P; Bergström CA; Norinder U; Hoogstraate J; Artursson P J Med Chem; 2008 Jun; 51(11):3275-87. PubMed ID: 18457386 [TBL] [Abstract][Full Text] [Related]
16. Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta. Neumanova Z; Cerveny L; Ceckova M; Staud F AIDS; 2014 Jan; 28(1):9-17. PubMed ID: 24413260 [TBL] [Abstract][Full Text] [Related]
17. Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Morris ME; Zhang S Life Sci; 2006 Mar; 78(18):2116-30. PubMed ID: 16455109 [TBL] [Abstract][Full Text] [Related]
18. Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2. Mease K; Sane R; Podila L; Taub ME J Pharm Sci; 2012 May; 101(5):1888-97. PubMed ID: 22359351 [TBL] [Abstract][Full Text] [Related]
19. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia. Ho MM; Hogge DE; Ling V Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061 [TBL] [Abstract][Full Text] [Related]
20. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. Dahan A; Amidon GL Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]